ATE332888T1 - Sphingosinderivate und medizinische zubereitung - Google Patents
Sphingosinderivate und medizinische zubereitungInfo
- Publication number
- ATE332888T1 ATE332888T1 AT98941825T AT98941825T ATE332888T1 AT E332888 T1 ATE332888 T1 AT E332888T1 AT 98941825 T AT98941825 T AT 98941825T AT 98941825 T AT98941825 T AT 98941825T AT E332888 T1 ATE332888 T1 AT E332888T1
- Authority
- AT
- Austria
- Prior art keywords
- sphingosine derivatives
- medical preparation
- different
- sphingosine
- same
- Prior art date
Links
- WWUZIQQURGPMPG-BXDGKWANSA-N (2R,3S,4Z)-2-aminooctadec-4-ene-1,3-diol Chemical class CCCCCCCCCCCCC\C=C/[C@H](O)[C@H](N)CO WWUZIQQURGPMPG-BXDGKWANSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000003410 sphingosines Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 150000003408 sphingolipids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26796597 | 1997-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332888T1 true ATE332888T1 (de) | 2006-08-15 |
Family
ID=17452059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98941825T ATE332888T1 (de) | 1997-09-11 | 1998-09-11 | Sphingosinderivate und medizinische zubereitung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6239297B1 (de) |
| EP (1) | EP1020429B1 (de) |
| JP (1) | JP4091250B2 (de) |
| KR (1) | KR100561890B1 (de) |
| AT (1) | ATE332888T1 (de) |
| AU (1) | AU9002298A (de) |
| DE (1) | DE69835223T2 (de) |
| WO (1) | WO1999012890A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2432978C (en) | 2000-12-22 | 2012-08-28 | Medlyte, Inc. | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| JP2004529100A (ja) * | 2001-01-30 | 2004-09-24 | ユニバーシティ オブ バージニア パテント ファウンデーション | スフィンゴシン−１−ホスフェートレセプターのアゴニストおよびアンタゴニスト |
| ITRM20010688A1 (it) | 2001-11-21 | 2003-05-21 | Univ Roma | Composti immunoregolatori. |
| US6838114B2 (en) * | 2002-05-24 | 2005-01-04 | Micron Technology, Inc. | Methods for controlling gas pulsing in processes for depositing materials onto micro-device workpieces |
| NL1022443C2 (nl) * | 2003-01-20 | 2004-07-22 | Tno | Sphingolipiden voor verbetering van de samenstelling van de darmflora. |
| DE102004025000A1 (de) * | 2004-05-21 | 2005-12-08 | Bayer Technology Services Gmbh | Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie |
| WO2006115509A2 (en) | 2004-06-24 | 2006-11-02 | Novartis Vaccines And Diagnostics Inc. | Small molecule immunopotentiators and assays for their detection |
| GB0513431D0 (en) * | 2005-06-30 | 2005-08-10 | Kherion Technology Ltd | Prophylactic compositions and uses |
| CN101460458A (zh) | 2006-02-15 | 2009-06-17 | 阿勒根公司 | 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物 |
| US8097644B2 (en) * | 2006-03-28 | 2012-01-17 | Allergan, Inc. | Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist |
| US9274129B2 (en) | 2006-05-31 | 2016-03-01 | Lpath, Inc. | Methods and reagents for detecting bioactive lipids |
| US8796429B2 (en) | 2006-05-31 | 2014-08-05 | Lpath, Inc. | Bioactive lipid derivatives, and methods of making and using same |
| US9217749B2 (en) | 2006-05-31 | 2015-12-22 | Lpath, Inc. | Immune-derived moieties reactive against lysophosphatidic acid |
| US9274130B2 (en) | 2006-05-31 | 2016-03-01 | Lpath, Inc. | Prevention and treatment of pain using antibodies to lysophosphatidic acid |
| PL2087002T3 (pl) | 2006-10-27 | 2015-02-27 | Lpath Inc | Kompozycje i sposoby do wiązania sfingozyno-1 fosforanu |
| US8524917B2 (en) * | 2007-01-11 | 2013-09-03 | Allergan, Inc. | 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
| MX2009007334A (es) | 2007-01-11 | 2009-07-15 | Allergan Inc | Compuestos de amida del acido indol-3-carboxilico 6-substituido que tienen actividad antagonista biologica del receptor esfingosina-1-fosfato (s1p). |
| BRPI0817397A2 (pt) * | 2007-09-24 | 2015-04-07 | Allergan Inc | Compostos indol contendo grupos arila ou heteroarila com atividade biológica do receptor de esfingosina-1-fosfato (sip) |
| US8143291B2 (en) | 2008-05-09 | 2012-03-27 | Allergan, Inc. | Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity |
| EP2328863A1 (de) * | 2008-08-12 | 2011-06-08 | Allergan, Inc. | Antagonisten des sphingosin-1-phosphat-(s1p-)rezeptors und methoden zu deren anwendung |
| US8871202B2 (en) | 2008-10-24 | 2014-10-28 | Lpath, Inc. | Prevention and treatment of pain using antibodies to sphingosine-1-phosphate |
| AU2010232556A1 (en) * | 2009-04-02 | 2011-11-03 | Allergan, Inc. | Prostaglandin E receptor antagonists |
| WO2011008475A1 (en) | 2009-06-30 | 2011-01-20 | Allergan, Inc. | Optionally substituted 2-(arylmethyl, aryloxy or arylthio) -n- pyridin-2 -yl-aryl acetamide or 2, 2-bis (aryl) -n-pyridin-2-yl acetamide compounds as medicaments for the treatment of eye diseases |
| US8168795B2 (en) | 2009-08-11 | 2012-05-01 | Allergan, Inc. | Selective sphingosine-1-phosphate receptor antagonists |
| WO2011028927A1 (en) | 2009-09-04 | 2011-03-10 | Allergan, Inc. | Selective sphingosine-1-phosphate receptor antagonists |
| CA2775587A1 (en) | 2009-09-29 | 2011-04-07 | Allergan, Inc. | Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors |
| US8741875B2 (en) | 2009-11-24 | 2014-06-03 | Allergan, Inc. | Compounds as receptor modulators with therapeutic utility |
| MX2012006028A (es) | 2009-11-24 | 2012-06-19 | Allergan Inc | Compuestos novedosos como moduladores de receptor con utilidad terapeutica. |
| BR112013012719A2 (pt) | 2010-11-22 | 2019-09-24 | Allergan Inc | "compostos como moduladores de receptor com utilidade terapêutica". |
| CA2850610A1 (en) * | 2011-09-29 | 2013-04-04 | Dennis C Liotta | Sphingosine analogs, compositions, and methods related thereto |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02215711A (ja) * | 1989-02-03 | 1990-08-28 | Biomembrane Inst | プロテインキナーゼ阻害剤としての、ｎ‐メチル‐スフィンゴシン誘導体及びその立体異性体 |
| JP2560250B2 (ja) * | 1994-03-18 | 1996-12-04 | 工業技術院長 | 天然型スフィンゴシン類の製造方法とその合成中間体 |
| EP0897988B1 (de) * | 1996-03-12 | 2005-04-13 | Takara Bio Inc. | Physiologisch aktive tkr1785's substanzen, verfahren zu ihrer herstellung und mikrobe |
-
1998
- 1998-09-11 AT AT98941825T patent/ATE332888T1/de not_active IP Right Cessation
- 1998-09-11 DE DE69835223T patent/DE69835223T2/de not_active Expired - Fee Related
- 1998-09-11 AU AU90022/98A patent/AU9002298A/en not_active Abandoned
- 1998-09-11 US US09/508,462 patent/US6239297B1/en not_active Expired - Fee Related
- 1998-09-11 KR KR1020007002122A patent/KR100561890B1/ko not_active Expired - Fee Related
- 1998-09-11 EP EP98941825A patent/EP1020429B1/de not_active Expired - Lifetime
- 1998-09-11 WO PCT/JP1998/004093 patent/WO1999012890A1/ja not_active Ceased
- 1998-09-11 JP JP2000510703A patent/JP4091250B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999012890A1 (fr) | 1999-03-18 |
| EP1020429A1 (de) | 2000-07-19 |
| EP1020429B1 (de) | 2006-07-12 |
| KR100561890B1 (ko) | 2006-03-16 |
| DE69835223T2 (de) | 2007-05-31 |
| KR20010023477A (ko) | 2001-03-26 |
| JP4091250B2 (ja) | 2008-05-28 |
| AU9002298A (en) | 1999-03-29 |
| US6239297B1 (en) | 2001-05-29 |
| DE69835223D1 (de) | 2006-08-24 |
| EP1020429A4 (de) | 2004-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69835223D1 (de) | Sphingosinderivate und medizinische zubereitung | |
| TR199701040T1 (xx) | Yeni taksoidler ve bunlar�n haz�rlanmas�. | |
| FR11C0038I1 (fr) | Analogues macrocycliques, leurs procedes d'utilisation et de preparation | |
| IL113462A0 (en) | Substituted pyridylpyrazoles, their preparation and pesticidal compositions containing them | |
| FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
| TR199701700T1 (xx) | Bile�imler ve bu bile�imleri i�eren farmas�tik terkipler | |
| ES2107284T3 (es) | Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2057959T3 (es) | Derivados de tienopiridina y composiciones farmaceuticas que los contienen. | |
| PT916651E (pt) | DERIVADOS DE áCIDO FENILALQUILCARBOXILICO | |
| TR199902350T2 (xx) | Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler. | |
| ATE229968T1 (de) | Diagnostisches mittel zur glykostoffwechselfunktion | |
| DE69001495D1 (de) | Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen. | |
| DK1362844T3 (da) | Benzylaminanalog | |
| DE69001111D1 (de) | Antikrebs-zusammensetzung. | |
| DE69118064D1 (de) | Diamino-s-Triazinonderivate und diese enthaltende selbstlöschende polymere Zusammensetzungen | |
| NO904187L (no) | Benzanilider. | |
| GR3031118T3 (en) | Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same | |
| SE8303913L (sv) | Heterocykliska foreningar | |
| ATE119898T1 (de) | Nmda-blockierende verbindungen, pharmazeutische präparate, deren herstellung und verwendung. | |
| ES2159843T3 (es) | Derivados de 5,11-dihidrodibenzo(b,e)(1,4)oxazepina y composiciones medicamentosas que los contienen. | |
| TR199801902A2 (xx) | S�lfonamid ile s�bstit�e edilmi� kromanlar, bunlar� i�eren farmakolojik bile�imler. | |
| DE69001004D1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| IL97053A0 (en) | Pharmaceutical compositions comprising azapirones for the treatment of sleep apneas | |
| ES2130491T3 (es) | Derivados de alquil-5-metilsulfonilbenzoilguanidina. | |
| ES2122751T3 (es) | Composicion antialergica que comprende un compuesto diester fosforico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |